Cargando…
Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
INTRODUCTION: Acute coronary syndrome (ACS) is a major cause of mortality worldwide. We have previously shown that increased interleukin-10 (IL-10) levels are associated with poor outcome in ACS patients. METHOD: We performed a genome-wide association study in 2864 ACS patients and 408 healthy contr...
Autores principales: | Johansson, Åsa, Alfredsson, Jenny, Eriksson, Niclas, Wallentin, Lars, Siegbahn, Agneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658192/ https://www.ncbi.nlm.nih.gov/pubmed/26600159 http://dx.doi.org/10.1371/journal.pone.0142518 |
Ejemplares similares
-
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008) -
Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021) -
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
por: Attelind, Sofia, et al.
Publicado: (2022) -
Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019) -
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021)